Scientists from the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of the Chinese Academy of Sciences have developed a lipid-rich mutant strain of Saccharomyces cerevisiae using a high-throughput, label-free screening technique, opening new possibilities for microbial production of palmitoleic acid—an omega-7 fatty acid with proven anti-inflammatory and metabolic benefits.